Financials data is unavailable for this security.
View more
Year on year Novo Integrated Sciences Inc grew revenues 7.11% from 11.74m to 12.57m while net income improved from a loss of 32.85m to a smaller loss of 13.21m.
Gross margin | 37.68% |
---|---|
Net profit margin | -180.11% |
Operating margin | -77.47% |
Return on assets | -68.51% |
---|---|
Return on equity | -133.23% |
Return on investment | -113.88% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Novo Integrated Sciences Inc fell by 1.76m. Cash Flow from Financing totalled 763.86k or 6.08% of revenues. In addition the company used 2.24m for operations while cash used for investing totalled 49.22k.
Cash flow per share | -1.30 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.5225 |
---|---|
Tangible book value per share | -0.6433 |
More ▼
Balance sheet in USDView more
Current ratio | 0.2717 |
---|---|
Quick ratio | 0.2227 |
Total debt/total equity | 0.2569 |
---|---|
Total debt/total capital | 0.2093 |
More ▼